KHSRP-mediated decay of axonally localized prenyl-Cdc42 mRNA slows nerve regeneration

Matthew D Zdradzinski1, Lauren S Vaughn1, Samaneh Matoo1

  • 1Department of Biological Sciences, University of South Carolina, Columbia, South Carolina, United States of America.

Plos Genetics
|November 7, 2025
PubMed

Insights

Growth inhibition reduces axonal Prenyl-Cdc42 mRNA, while KHSRP protein binding decreases its levels. Depleting KHSRP accelerates nerve regeneration by increasing axonal Prenyl-CDC42.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Biology

Background:

  • Axon growth is regulated by the small GTPase CDC42, involving actin polymerization.
  • Axonal localization and translation of Prenyl-Cdc42 mRNA drive axon growth.
  • RhoA signaling also plays a role in axonal responses to growth stimuli.

Purpose of the Study:

  • To investigate the regulation of axonal Prenyl-Cdc42 mRNA levels and translation.
  • To determine the role of KHSRP in controlling axonal Prenyl-Cdc42 mRNA.
  • To elucidate the mechanisms underlying nerve regeneration influenced by KHSRP and Prenyl-CDC42.

Main Methods:

  • Quantitative analysis of axonal mRNA levels under different stimulation conditions.
  • Investigation of mRNA transport and translation regulation.
  • KHSRP protein binding assays and analysis of Khsrp-/- mouse models.
  • Sciatic nerve regeneration studies.

Main Results:

  • Axonal Prenyl-Cdc42 mRNA levels and translation decrease with growth-inhibiting stimuli and increase with growth-promoting stimuli.
  • Axonal RhoA mRNA transport and translation increase with growth inhibition.
  • KHSRP, upregulated by calcium signaling, binds Prenyl-Cdc42 mRNA, reducing its axonal levels.
  • Khsrp-/- mice exhibit increased axonal Prenyl-Cdc42 mRNA, leading to accelerated nerve regeneration.

Conclusions:

  • Axonal Prenyl-Cdc42 mRNA levels are dynamically regulated by neuronal stimulation and KHSRP.
  • KHSRP acts as a negative regulator of axonal Prenyl-Cdc42 mRNA levels.
  • KHSRP depletion promotes nerve regeneration by increasing axonal Prenyl-CDC42, highlighting its therapeutic potential.